Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosides

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|December 1, 1980
PubMed

Insights

Cytotoxic drugs and aminoglycosides can cause kidney damage, indicated by elevated urinary biomarkers. Methotrexate showed the most significant effects, while aminoglycosides also caused protein in urine, especially in vulnerable patients.

Area of Science:

  • Nephrology
  • Oncology
  • Pharmacology

Background:

  • Cytotoxic agents and aminoglycosides are commonly used in cancer therapy and for treating infections.
  • Renal toxicity is a known side effect of these drug classes.
  • Early detection of kidney damage is crucial for patient management.

Purpose of the Study:

  • To evaluate the impact of cytotoxic agents and aminoglycosides on renal tubular function.
  • To identify specific drugs causing the most significant tubular damage.
  • To assess the risk factors for drug-induced kidney injury in vulnerable patient populations.

Main Methods:

  • Monitoring urinary biomarkers: beta 2-microglobulin (beta 2-m), N-acetyl-beta-D-glucosaminidase (NAG), and total protein.
  • Assessing renal function in patients receiving cytotoxic drugs and/or aminoglycosides for up to eleven days.
  • Comparing the degree of tubular damage across different drug regimens and patient groups.

Main Results:

  • Both cytotoxic agents and aminoglycosides led to increased urinary beta 2-m, NAG, and total protein, indicating renal tubular damage.
  • Methotrexate (MTX) induced the most pronounced tubular changes among the cytotoxic agents studied.
  • Aminoglycosides, even at prophylactic doses, caused tubuloproteinuria, with the most severe damage observed in patients with hematological malignancies receiving them for sepsis post-chemotherapy.
  • No evidence of glomerular damage or increased glomerular permeability was found seven days after chemotherapy initiation.

Conclusions:

  • Short-term administration of cytotoxic agents and aminoglycosides can cause significant renal tubular injury.
  • Methotrexate and aminoglycosides are key agents associated with this toxicity.
  • Vulnerable patient groups, such as those with hematological malignancies undergoing chemotherapy and treated for sepsis, are at higher risk for aminoglycoside-induced nephrotoxicity.

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...